taxonomy (8)
protein (61)
source (18)
structure (24)
composition (1)
disease (7)
reference (25)
site (78)
peptide (70)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Ovis aries (Sheep)
- Rattus norvegicus (Norway rat)
- Sus scrofa (Pig)
- Calloselasma rhodostoma (Malayan pit viper)
- Human immunodeficiency virus type 1 (HIV-1)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Asporin / Homo sapiens Q9BXN1
- Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe / Homo sapiens Q8NES3
- Biglycan / Homo sapiens P21810
- Calponin-3 / Homo sapiens Q15417
- Calsyntenin-2 / Homo sapiens Q9H4D0
- CD59 glycoprotein / Homo sapiens P13987
- Ceruloplasmin / Homo sapiens P00450
- Clusterin / Homo sapiens P10909
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-1(XIV) chain / Homo sapiens Q05707
- Decorin / Homo sapiens P07585
- Fibromodulin / Homo sapiens Q06828
- Fibulin-5 / Homo sapiens Q9UBX5
- GDNF family receptor alpha-1 / Homo sapiens P56159
- Glucosylceramidase / Homo sapiens P04062
- Glycodelin-a / Homo sapiens P09466
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens P01215
- Golgi apparatus protein 1 / Homo sapiens Q92896
- Golgi membrane protein 1 / Homo sapiens Q8NBJ4
- Inactive tyrosine-protein kinase 7 / Homo sapiens Q13308
- Inositol monophosphatase 3 / Homo sapiens Q9NX62
- Kininogen-1 / Homo sapiens P01042
- Lactotransferrin / Homo sapiens P02788
- Lumican / Homo sapiens P51884
- Lutropin beta chain / Homo sapiens P01229
- Mammaglobin-A / Homo sapiens Q13296
- Metalloproteinase inhibitor 1 / Homo sapiens P01033
- Olfactomedin-4 / Homo sapiens Q6UX06
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Periostin / Homo sapiens Q15063
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prolactin-inducible protein / Homo sapiens P12273
- Prolargin / Homo sapiens P51888
- Prominin-1 / Homo sapiens O43490
- Prosaposin / Homo sapiens P07602
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Prostate-specific antigen (psa-1) / Homo sapiens P07288
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens P07288
- Protein YIPF3 / Homo sapiens Q9GZM5
- Stanniocalcin-2 / Homo sapiens O76061
- Thrombospondin-1 / Homo sapiens P07996
- Tissue-type plasminogen activator / Homo sapiens P00750
- Translocon-associated protein subunit alpha / Homo sapiens P43307
- Uromodulin / Homo sapiens P07911
- Vitamin k-dependent protein c / Homo sapiens P04070
- WAP four-disulfide core domain protein 2 / Homo sapiens Q14508
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Acetylcholinesterase / Bos taurus P23795
- Major prion protein (VRQ/VRQ polymorphism) 21K slow variant / Ovis aries Q712V9
- Major prion protein (VRQ/VRQ polymorphism) CH1641 variant / Ovis aries Q712V9
- Neuroligin 1 / Rattus norvegicus Q62765
- 32 kDa enamelin / Sus scrofa O97939
- Major seminal plasma glycoprotein psp-i / Sus scrofa P35495
- Major seminal plasma glycoprotein psp-ii / Sus scrofa P35496
- Mucin / Sus scrofa
- Ancrod / Calloselasma rhodostoma P26324
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Amniotic Fluid (UBERON_0000173)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Enamel Organ (UBERON_0005176)
- Kidney (UBERON_0002113) HEK293-EBNA (CVCL_6974)
- Kidney (UBERON_0002113)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Pituitary Gland (UBERON_0000007)
- Prefrontal Cortex (UBERON:0000451)
- Seminal Fluid (UBERON_0006530)
- Skin of Body (UBERON_0002097) HMCB (CVCL_3317)
- Trachea (UBERON_0003126)
- Urine (UBERON_0001088)
- Venom (UBERON_0007113)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- HEK293SF-3F6 (CVCL_4V95)
Source
- N-Linked / Complex / NeuAc(?2-?)Hex(?1-?)HexNAc(?1-?)Man(a1-?)[NeuAc(?2-?)HexNAc(?1-?)HexNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(?1-?)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[NeuAc(a2-?)GalNAc(?1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
- N-Linked / Complex / Structure 9386
- N-Linked / Complex / Structure 9599
- N-Linked / Complex / Structure 9823
- N-Linked / Complex / Structure 9946
- N-Linked / Complex / Structure 10051
- N-Linked / Complex / Structure 10106
- N-Linked / Complex / Structure 10710
- N-Linked / Complex / Structure 10810
- N-Linked / Complex / Structure 10982
- N-Linked / Complex / Structure 11464
- N-Linked / Complex / Structure 11680
- N-Linked / Complex / Structure 11815
- N-Linked / Complex / Structure 11851
- N-Linked / Undefined core / NeuAc(??-?)HexNAc(??-?)HexNAc(??-?)Hex(??-?)[NeuAc(??-?)Hex(??-?)HexNAc(??-?)Hex(??-?)]Hex(??-?)HexNAc(??-?)[Fuc(??-?)]HexNAc
- O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-3)[GlcNAc(b1-6)]Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Structure 9479
Reported structure
- Cancer, breast (DOID:1612)
- COVID-19 (DOID:0080600)
- Melanoma (DOID:1909)
- Oral squamous cell carcinoma (DOID:0050866)
- Prostate cancer (DOID:10283)
- Prostate Disease (DOID:47)
- Scrapie (DOID:5434)
Disease
- Differential N- and O-glycosylation signatures of HIV-1 Gag virus-like particles and coproduced extracellular vesicles (2022 - Lavado-García J, Zhang T, Cervera L, Gòdia F, Wuhrer M) / Status : Reviewed
- High-throughput glycopeptide profiling of prostate-specific antigen from seminal plasma by MALDI-MS. (2021 - Wei Wang, Anna Kałuża, Jan Nouta, Simone Nicolardi, Mirosława Ferens-Sieczkowska, Manfred Wuhrer, Guinevere S M Lageveen-Kammeijer, Noortje de Haan) / Status : Reviewed
- Site-specific analysis of N-glycans from different sheep prion strains (2021 - Natali Nakić ,Thanh Hoa Tran ,Mislav Novokmet,Olivier Andreoletti,Gordan Lauc,Giuseppe Legname) / Status : Reviewed
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry (2021 - Alan B. Moran, Elena Domínguez-Vega, Jan Nouta, Tamas Pongracz, Theo M. de Reijke, Manfred Wuhrer, Guinevere S.M. Lageveen-Kammeijer) / Status : Reviewed
- N-Glycosylation in isolated rat nerve terminals (2021 - Matthies I, Abrahams JL, Jensen P, Oliveira T, Kolarich D, Larsen MR) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Novel O-linked sialoglycan structures in human urinary glycoproteins (2020 - Adam Pap, Ervin Tasnadi, Katalin F. Medzihradszky, Zsuzsanna Darula ) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Spatial and temporal diversity of glycome expression in mammalian brain (2020 - Lee J, Ha S, Kim M, Kim SW, Yun J, Ozcan S, Hwang H, Ji IJ, Yin D, Webster MJ, Shannon Weickert C, Kim JH, Yoo JS, Grimm R, Bahn S, Shin HS, An HJ) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Tongue Cancer Patients Can be Distinguished from Healthy Controls by Specific N-Glycopeptides Found in Serum. (2018 - Mayank Saraswat, Antti Mäkitie, Tiialotta Tohmola, Amy Dickinson, Shruti Saraswat, Sakari Joenväärä, Suvi Renkonen) / Status : Reviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry. (2004 - Hoffman RC, Jennings LL, Tsigelny I, Comoletti D, Flynn RE, Sudhof TC, Taylor P) / Status : Reviewed
- Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase. (2000 - Kronman C, Chitlaru T, Elhanany E, Velan B, Shafferman A) / Status : Reviewed
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- Carbohydrate moieties of porcine 32 kDa enamelin. (1995 - Yamakoshi Y) / Status : Reviewed
- Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. (1995 - Dell A, Morris H, Easton R, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M, Clark G) / Status : Reviewed
- Novel Asn-linked oligosaccharides terminating in GalNAc beta (1-->4)[Fuc alpha (1-->3)]GlcNAc beta (1-->.) are present in recombinant human protein C expressed in human kidney 293 cells. (1993 - Yan S, Chao Y, van Halbeek H) / Status : Reviewed
- Carbohydrate structure of a thrombin-like serine protease from Agkistrodon rhodostoma. Structure elucidation of oligosaccharides by methylation analysis, liquid secondary-ion mass spectrometry and proton magnetic resonance. (1992 - Pfeiffer G, Dabrowski U, Dabrowski J, Stirm S, Strube K, Geyer R) / Status : Reviewed
- A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator. (1991 - Chan A, Morris H, Panico M, Etienne A, Rogers M, Gaffney P, Creighton-Kempsford L, Dell A) / Status : Reviewed
- NMR investigations of the N-linked oligosaccharides at individual glycosylation sites of human lutropin. (1991 - Weisshaar G, Hiyama J, Renwick A, Nimtz M) / Status : Reviewed
- Structures of the sialylated oligosaccharide chains in swine tracheal mucin glycoproteins. (1987 - Rana SS, Chandrasekaran EV, Mendicino J) / Status : Reviewed
Reference
- Alpha-2-HS-glycoprotein / Homo sapiens
- Asporin / Homo sapiens
- Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe / Homo sapiens
- Biglycan / Homo sapiens
- Calponin-3 / Homo sapiens
- Calsyntenin-2 / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Decorin / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibulin-5 / Homo sapiens
- GDNF family receptor alpha-1 / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Glycodelin-a / Homo sapiens
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Golgi membrane protein 1 / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Inositol monophosphatase 3 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lumican / Homo sapiens
- Lutropin beta chain / Homo sapiens
- Mammaglobin-A / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Olfactomedin-4 / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prominin-1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- Protein YIPF3 / Homo sapiens
- Stanniocalcin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Tissue-type plasminogen activator / Homo sapiens
- Translocon-associated protein subunit alpha / Homo sapiens
- Uromodulin / Homo sapiens
-
Vitamin k-dependent protein c / Homo sapiens
- Undefined site
- WAP four-disulfide core domain protein 2 / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Acetylcholinesterase / Bos taurus
- Undefined site
- Major prion protein (VRQ/VRQ polymorphism) 21K slow variant / Ovis aries
- Major prion protein (VRQ/VRQ polymorphism) CH1641 variant / Ovis aries
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
-
32 kDa enamelin / Sus scrofa
- Undefined site
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
Mucin / Sus scrofa
- Undefined site
-
Ancrod / Calloselasma rhodostoma
- Undefined site
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- TAVNCSSDFDACLITK (16aa)
- TGVCPELQADQNCTQECVSDSECADNLK (28aa)
- WFSAGLASNSSWLR (14aa)
- ELLQEFIDDNATTNAIDELK (20aa)
- FVGTPEVNQTTIYQR (15aa)
- ETNFSIASGIEAK (13aa)
- AVCGGVLVHPQWVLTAAHCIRNK (23aa)
- AVCGGVLVHPQWVLTAAHCIRNKSVILLGR (30aa)
- NKSVLLGR (8aa)
- NK (2aa)
- LSLQNTAEIQHCLVNAGDVGCGVFECFENNSCEIR (35aa)
- SVVAPATDGGLNLTSTFLRK (20aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- KEDALNETR (9aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- AIIQGLMPDQNYTVQIIAYNK (21aa)
- IHGQELPFEAVVLNK (15aa)
- TCDWIPKPNMSASCK (15aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TFYWDFYTNR (10aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- AVIVNNITTGER (12aa)
- SANASFNIK (9aa)
- TQSLLIVNNATNVVIK (16aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- FYIQNFTALPLNTVVPPQR (19aa)
- EHEGAIYPDNTTDFQR (16aa)
- TAGWNVPIGTIRPFINWTGPPEPIEAAVAR (30aa)
- IYIDHNNITR (10aa)
- HTGNVVITNCSAAHSR (16aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- IYVIDGTQNDTAFVFPR (17aa)
- YPNQVYYRPVDQYSNQNNFVHDCVNITVK (29aa)
- GNITEYQCHQYITK (14aa)
- TNSTFVQALVEHVK (14aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- ITIQPVDNSTISIQMGTNK (19aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- QVAIQTFGNQTTIIPAGGAGYK (22aa)
- GLSFNSISAVDNGSLANTPHLR (22aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- MIENGSISFIPTIR (14aa)
- EALENMNSTLK (11aa)
- ITDIENGSIANIPR (14aa)
- NVSVAEGK (8aa)
- LNAENNATFYFK (12aa)
- SCQDINECEHRNHTCNLQQTCYNLQGGFK (29aa)
- YIQVVYLHNNNISVVGSSDFCPPGHNTK (28aa)
- DIGPTIANSTHHNVR (15aa)
- IIQVVYIHSNNITK (14aa)
- LQVVYLHSNNITK (13aa)
- QDFNITDISLLEHR (14aa)
- INGTQICPNDIVAFHDFSSDIENVPHIR (28aa)
- FPNIT (5aa)
- RFPNIT (6aa)
- IIDNNKTEK (9aa)
- AVAVTLQSH (9aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- AGIQAFFQVQECNK (14aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- IANITQGEDQYYIR (14aa)
- LNDTTLQVLNTWYTK (15aa)
- LSLLEEPGNGTFTVILNQLTSR (22aa)
- VPGNVTAVLGETLK (14aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- EVNDTLLVNELK (12aa)
- EAGNITTDGYEIIGK (15aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 2411.2187)
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Enamel Organ (UBERON_0005176)
- Carbohydrate moieties of porcine 32 kDa enamelin. (1995 - Yamakoshi Y) / Status : Reviewed
-
32 kDa enamelin / Sus scrofa
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Venom (UBERON_0007113)
-
Ancrod / Calloselasma rhodostoma
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Novel Asn-linked oligosaccharides terminating in GalNAc beta (1-->4)[Fuc alpha (1-->3)]GlcNAc beta (1-->.) are present in recombinant human protein C expressed in human kidney 293 cells. (1993 - Yan S, Chao Y, van Halbeek H) / Status : Reviewed
- NMR investigations of the N-linked oligosaccharides at individual glycosylation sites of human lutropin. (1991 - Weisshaar G, Hiyama J, Renwick A, Nimtz M) / Status : Reviewed
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens
- Lutropin beta chain / Homo sapiens
-
Vitamin k-dependent protein c / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Melanoma (DOID:1909)
- Tissue-type plasminogen activator / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Seminal Fluid (UBERON_0006530)
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Amniotic Fluid (UBERON_0000173)
- Glycodelin-a / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Kidney (UBERON_0002113)
-
Acetylcholinesterase / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Milk (UBERON_0001913)
- Lactotransferrin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Brain (UBERON_0000955)
- Scrapie (DOID:5434)
- Major prion protein (VRQ/VRQ polymorphism) 21K slow variant / Ovis aries
- Major prion protein (VRQ/VRQ polymorphism) CH1641 variant / Ovis aries
- YPNQVYYRPVDQYSNQNNFVHDCVNITVK (29aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Urine (UBERON_0001088)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Urine (UBERON_0001088)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- AVCGGVLVHPQWVLTAAHCIRNK (23aa)
- AVCGGVLVHPQWVLTAAHCIRNKSVILLGR (30aa)
- NKSVLLGR (8aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- HEK293SF-3F6 (CVCL_4V95)
-
- N-Linked / Complex
(avg mass : 2411.2187)
-
- N-Linked / Complex
(avg mass : 2411.2187)
-
- N-Linked / Complex
(avg mass : 2411.2187)
-
- N-Linked / Undefined core
(avg mass : 2411.2187)
- Blood Serum (UBERON_0001977)
- Alpha-2-HS-glycoprotein / Homo sapiens
- AALAAFNAQNNGSNFQLEEISR (22aa)
-
- O-Linked / Core 2
(avg mass : 2411.2187)
- Trachea (UBERON_0003126)
-
Mucin / Sus scrofa
- Undefined site
-
- O-Linked / Core 2
(avg mass : 2411.2187)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2411.2187)
- N-Linked / Complex / NeuAc(?2-?)Hex(?1-?)HexNAc(?1-?)Man(a1-?)[NeuAc(?2-?)HexNAc(?1-?)HexNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(?1-?)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[NeuAc(a2-?)GalNAc(?1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
- N-Linked / Complex / Structure 9386
- N-Linked / Complex / Structure 9599
- N-Linked / Complex / Structure 9823
- N-Linked / Complex / Structure 9946
- N-Linked / Complex / Structure 10051
- N-Linked / Complex / Structure 10106
- N-Linked / Complex / Structure 10710
- N-Linked / Complex / Structure 10810
- N-Linked / Complex / Structure 10982
- N-Linked / Complex / Structure 11464
- N-Linked / Complex / Structure 11680
- N-Linked / Complex / Structure 11815
- N-Linked / Complex / Structure 11851
- N-Linked / Undefined core / NeuAc(??-?)HexNAc(??-?)HexNAc(??-?)Hex(??-?)[NeuAc(??-?)Hex(??-?)HexNAc(??-?)Hex(??-?)]Hex(??-?)HexNAc(??-?)[Fuc(??-?)]HexNAc
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Asporin / Homo sapiens
- Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe / Homo sapiens
- Biglycan / Homo sapiens
- Calponin-3 / Homo sapiens
- Calsyntenin-2 / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Decorin / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibulin-5 / Homo sapiens
- GDNF family receptor alpha-1 / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Golgi membrane protein 1 / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Inositol monophosphatase 3 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lumican / Homo sapiens
- Mammaglobin-A / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Olfactomedin-4 / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prominin-1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Stanniocalcin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Translocon-associated protein subunit alpha / Homo sapiens
- Uromodulin / Homo sapiens
- WAP four-disulfide core domain protein 2 / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TAVNCSSDFDACLITK (16aa)
- TGVCPELQADQNCTQECVSDSECADNLK (28aa)
- WFSAGLASNSSWLR (14aa)
- ELLQEFIDDNATTNAIDELK (20aa)
- FVGTPEVNQTTIYQR (15aa)
- ETNFSIASGIEAK (13aa)
- LSLQNTAEIQHCLVNAGDVGCGVFECFENNSCEIR (35aa)
- SVVAPATDGGLNLTSTFLRK (20aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- KEDALNETR (9aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- AIIQGLMPDQNYTVQIIAYNK (21aa)
- IHGQELPFEAVVLNK (15aa)
- TCDWIPKPNMSASCK (15aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TFYWDFYTNR (10aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- AVIVNNITTGER (12aa)
- SANASFNIK (9aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- FYIQNFTALPLNTVVPPQR (19aa)
- EHEGAIYPDNTTDFQR (16aa)
- TAGWNVPIGTIRPFINWTGPPEPIEAAVAR (30aa)
- IYIDHNNITR (10aa)
- HTGNVVITNCSAAHSR (16aa)
- IYVIDGTQNDTAFVFPR (17aa)
- GNITEYQCHQYITK (14aa)
- TNSTFVQALVEHVK (14aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- ITIQPVDNSTISIQMGTNK (19aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- QVAIQTFGNQTTIIPAGGAGYK (22aa)
- GLSFNSISAVDNGSLANTPHLR (22aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- MIENGSISFIPTIR (14aa)
- EALENMNSTLK (11aa)
- ITDIENGSIANIPR (14aa)
- NVSVAEGK (8aa)
- LNAENNATFYFK (12aa)
- SCQDINECEHRNHTCNLQQTCYNLQGGFK (29aa)
- YIQVVYLHNNNISVVGSSDFCPPGHNTK (28aa)
- DIGPTIANSTHHNVR (15aa)
- IIQVVYIHSNNITK (14aa)
- LQVVYLHSNNITK (13aa)
- QDFNITDISLLEHR (14aa)
- INGTQICPNDIVAFHDFSSDIENVPHIR (28aa)
- RFPNIT (6aa)
- IIDNNKTEK (9aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- AGIQAFFQVQECNK (14aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- IANITQGEDQYYIR (14aa)
- LNDTTLQVLNTWYTK (15aa)
- LSLLEEPGNGTFTVILNQLTSR (22aa)
- VPGNVTAVLGETLK (14aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- EVNDTLLVNELK (12aa)
- EAGNITTDGYEIIGK (15aa)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- O-Linked / Core 2
(avg mass : 2411.2187)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Undefined core
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)